Карта сайта "Остановка Гепатит С"

• Облысение и пересадка волос

HEPATITIS C FAQ HepCBC - Часто задаваемые вопросы по гепатиту С (на английском языке)

• Preface
• Administrivia
• 0.01 Introduction
• 0.02 Disclaimer
• THE BASICS
• 1.0.2 WHAT HAPPENS IN THE BODY?
• 1.0.3 WHAT IS THE INCUBATION PERIOD?
• 1.0.4 HOW DOES HEPATITIS C USUALLY BEGIN?
• 1.0.5 WHAT ARE THE DIFFERENT TYPES OF HEPATITIS?
• 1.0.6 WHAT IS THE FUNCTION OF THE LIVER?
• 1.0.7 HEPATITIS C VIRUS (HCV)
• 1.0.7a WHEN WAS THE HEPATITIS C VIRUS DISCOVERED?
• 1.0.8 WHO GETS HEPATITIS?
• 1.1.0 HOW IS IT TRANSMITTED?
• 1.1.0a HOW HCV IS NOT TRANSMITTED
• 1.1.1 HCV AND BLOOD TRANSFUSIONS
• 1.1.2 HCV AND INTRAVENOUS DRUG USE
• 1.1.3 HCV AND IV IMMUNOGLOBULIN (GAMMAGARD/POLYGAM/FACTOR D)
• 1.1.4 NEONATAL TRANSFER OF HCV
• 1.1.5 OTHER MEANS OF HCV TRANSMISSION
• 1.1.5a SEXUAL TRANSMISSION
• 1.1.5b OCCUPATIONAL EXPOSURE (HEALTH CARE WORKERS)
• 1.1.5c TOOTHBRUSHES/RAZORS/NAIL CLIPPERS
• 1.1.5d HEMODIALYSIS
• 1.1.6 HIGHLY SPECULATIVE MODES OF TRANSMISSION OF HCV
• 1.1.6a TEARS, SALIVA, URINE, AND OTHER BODY FLUIDS
• 1.1.6b CAT SCRATCHES
• 1.1.6c MOSQUITOS
• 1.1.6d ALTERNATIVE MEDICAL PROCEDURES
• 1.1.6e HOUSEHOLD TRANSMISSION
• 1.1.6f OTHER
• 1.1.6g IS HCV ANYTHING LIKE HIV?
• 1.1.7 PREVENTION
• 1.1.7a WHEN, AND FOR HOW LONG, IS A PERSON ABLE TO SPREAD THE HEPATITIS C VIRUS?
• 1.1.7b HOW CAN THE SPREAD OF HEPATITIS C BE PREVENTED?
• 1.1.7c CLEANING UP BLOOD SPILLS
• 1.1.7d WHAT TO DO IN CASE OF AN ACCIDENTAL NEEDLESTICK
• 1.1.8 WHOM SHOULD I TELL?
• 1.1.9 CAN YOU GET HEPATITIS MORE THAN ONCE?
• MEDICAL ISSUES
• 2.0.2 WHAT IS THE DIFFERENCE BETWEEN A GASTROENTEROLOGIST AND A HEPATOLOGIST?
• 2.1.0 HOW IS IT DIAGNOSED?
• 2.1.1 ANTIBODY TESTS
• 2.1.2 WHAT IS A PCR?
• 2.1.2a WHAT IS A GENOTYPE?
• 2.1.3 IS IT POSSIBLE THE TEST COULD BE WRONG?
• 2.2.0 BIOPSY
• .2.0a WHAT IS A LIVER BIOPSY?
• 2.2.0b WHAT ARE THE DANGERS OF LIVER BIOPSY ?
• 2.2.0c WILL IT HURT?
• 2.2.1 CHRONIC PERSISTENT OR CHRONIC ACTIVE - WHAT’S THE DIFFERENCE?
• 2.2.2 WHAT ARE THE MAIN SYMPTOMS OF HEPATITIS C?
• 2.2.2a FATIGUE
• 2.2.2b UPPER RIGHT QUADRANT (URQ) PAIN (SIDE PAIN)
• 2.2.2c LOSS OF LIBIDO
• 2.2.2d RED PALMS
• 2.2.2e NAUSEA
• 2.2.2f BRAIN FOG
• 2.2.2g ITCHING
• 2.2.2h VISION PROBLEMS
• 2.2.2i DIZZINESS
• 2.2.2j DRY MOUTH
• 2.3.0 IT’S NOT ALL IN YOUR HEAD!
• 2.3.1 WHAT IS THE EVOLUTION OF THE DISEASE?
• 2.4.0 WHAT OTHER MEDICAL PROBLEMS CAN BE RELATED TO HCV?
• 2.4.0a CRYOGLOBULINEMIA
• 2.4.0b THYROID AND AUTOIMMUNE PROBLEMS
• 2.4.0c RHEUMATOID ARTHRITIS-LIKE SYMPTOMS
• 2.4.0d FIBROMYALGIA
• 2.4.0e DERMATOLOGICAL MANIFESTATIONS
• 2.4.0f PORPHYRIA CUTANEA TARDA (PCT)
• 2.4.0g LICHEN PLANUS
• 2.5.0 CYCLES AND FLARE-UPS
• 2.6.0 SHOULD I BE VACCINATED AGAINST OTHER TYPES OF HEPATITIS?
• 2.7.0 HCV AND WOMEN’S CONCERNS
• 2.7.1 PREGNANCY AND BREASTFEEDING
• 2.8.0 HOW DOES HCV AFFECT CHILDREN?
• 2.9.0 WHAT ARE THE DIFFERENT CLINICAL INDICATIONS OF HCV?
• 2.9.1 ELEVATED LIVER ENZYMES
• 2.9.1a ELEVATED ALPHA-FETOPROTEIN LEVELS
• 2.9.2 JAUNDICE
• 2.9.3 HEPATOMEGALY, SPLENOMEGALY
• 2.9.4 SPIDER NEVI
• 2.9.5 ASCITES
• 2.9.6 PORTAL HYPERTENSION / VARICES
• 2.9.7 HEPATIC ENCEPHALOPATHY
• 2.9.8 CIRRHOSIS
• 2.9.9 FULMINANT HEPATITIS
• 2.9.10 DOES HCV INCREASE THE LIKELIHOOD OF CANCER?
• 2.10.0 HOW MANY OF US ARE THERE?
• TREATMENT (Conventional Medicine)
• 3.1.1 Interferon Monotherapy
• 3.1.1a Interferon Alpha 2B, Recombinant (Intron A)
• 3.1.1b When Is Interferon Treatment Not Indicated?
• 3.1.1c Interferon “Breakthrough” and “Non-Response”
• 3.1.1d Consensus Interferon (Infergen)
• 3.1.1e Natural Source Interferon Alpha-N3 – Human Leukocyte-Derived (Alferon)
• 3.1.1f Beta Interferon, Recombinant (Betaseron, Avonex and Rebif)
• 3.1.1g Roferon INTERFERON ALPHA 2A, RECOMBINANT
• 3.1.1h Lymphoblastoid IFN
• 3.1.1i Mochida Interferon (Alpha IFN-alpha Mochida500)
• 3.1.1j Multiferon
• 3.1.1k Veldona Oral Alpha-IFN
• 3.1.1l Omega IFN (Biomed 510)
• 3.1.1m Albuferon
• 3.1.2 Pegylated Interferon
• 3.1.2a Pegylated Intron A (Peg-Intron A)
• 3.1.2b Peginterferon Alpha-2a (Pegasys)
• 3.1.3 Interferon Combinations
• 3.1.3a Interferon and Ribavirin Combined (Rebetron)
• 3.1.3b Pegylated IFN and Ribavirin
• 3.1.3c Interferon and Iron Reduction Therapy
• 3.1.3d Interferon and Thymosin
• 3.1.3e Interferon and GM-CSF
• 3.1.3f Interferon and NAC
• 3.1.3g Interferon and Amantadine
• 3.1.3h Interferon and Ofloxacin
• 3.1.3i Interferon and Histamine Dihydrochloride (Ceplene)
• 3.1.3j IFN and Ketoprofen
• 3.1.3k IFN and Ursodeoxycholic Acid (Actigall)
• 3.1.3l IFN and VX-497
• 3.1.3m IFN and Colchicine
• 3.1.3n Triple Therapy
• 3.1.4 Different Dosage
• 3.1.4a Mega Dosing
• 3.1.4b Maintenance Dosing
• 3.1.4c Induction dosing
• 3.1.4d Longer Treatment
• 3.2.0 INTERLEUKINS
• 3.2.1 Interleukin-10
• 3.2.2 Interleukin-12
• 3.3.0 HCV PROTEIN-BASED THERAPY (or GENE THERAPY or RNA INHIBITORS)
• 3.3.1 Protease Inhibitors
• 3.3.2 Polymerase Inhibitors
• 3.3.3 Helicase Inhibitors
• 3.3.4 Reverse Transcriptase Inhibitors
• 3.3.5 VP-50406
• 3.3.6 Interferon Alpha Gene Therapy
• 3.3.7 Ribozyme Therapy
• 3.3.8 IRES Inhibitors
• 3.3.9 Antisense Based Therapies
• 3.4.0 VACCINES
• 3.4.1 HCV Antibody
• 3.4.2 InnoVac-C
• 3.4.3 HepeX-C (formerly XTL-002)
• 3.4.4 Epimmune Vaccine
• 3.4.5 Vical technology
• 3.4.6 ChimeriVax Vaccine
• 3.4.7 Chiron Vaccine
• 3.4.8 Iscoprep 703 (ISCOM)
• 3.4.9 Therapore
• 3.4.10 Antigen-specific cellular therapy
• 3.5.0 OTHER THERAPIES
• 3.5.1 Nucleoside Analogs
• 3.5.2 ACH-126447 (Helioxanthin)
• 3.5.3 Ampligen
• 3.5.4 EHC18 (Enzo Immune Regulator)
• 3.5.5 Geron Telomerase Activation
• 3.5.6 HE2000
• 3.5.7 Hypericin (Vimrx, Hifritzen)
• 3.5.8 Immtech Mono and Dication Compounds
• 3.5.9 IP501
• 3.5.10 Macrokine (WF10)
• 3.5.11 S-28463 (R-848; VML-600)
• 3.5.12 NCX-1000
• 3.6.0 TRANSPLANT
• 3.7.0 OTHERS
• TREATMENT (Alternative Medicine)
• 4.0.1 ACUPUNCTURE
• 4.0.2 CHIROPRACTIC
• 4.0.3 ENERGY HEALING (Reiki, Hands of Light, Touch Therapy etc)
• 4.0.4 REFLEXOLOGY
• 4.0.5 HOMEOPATHY
• 4.0.6 RETICULOSE
• 4.0.7 TRADITIONAL CHINESE MEDICINE (TCM)
• 4.0.8 OZONE THERAPY
• 4.1.0 HERBAL TREATMENTS AND VITAMINS
• 4.1.1 KOMBUCHA TEA
• 4.1.2 MEDICINAL MUSHROOMS (REISHI / MAITAKE, SHITAKE)
• 4.1.3 DANDELION (Taraxacum officinale)
• 4.1.4 MILK THISTLE
• 4.1.5 ARTICHOKE (cynara scolymus)
• 4.1.6 LICORICE ROOT (glycyrrhiza glabra)
• 4.1.7 SPIRULINA (BLUE-GREEN ALGAE)
• 4.1.8 GARLIC
• 4.1.9 THYMIC FACTORS
• 4.1.10 VITAMIN C
• 4.1.11 VITAMIN B12
• 4.1.12 VITAMIN E
• 4.1.13 NATURAL INTERFERON BOOSTERS
• 4.1.14 OTHER HERBS OR VITAMINS
• 4.1.15 WATER
• 4.2.0 EXERCISE
• 4.3.0 STRESS MANAGEMENT
• 4.4.0 POSITIVE ATTITUDE
• 4.5.0 TAI CHI / CHI KUNG / YOGA / MEDITATION
• 4.6.0 OTHER WAYS TO HELP KEEP YOURSELF HEALTHY
• NUTRITION
• 5.1.1 FOODS TO AVOID:
• 5.2.0 NUTRITION AND CIRRHOSIS
• 5.3.0 COFFEE, TEA, CAFFEINE AND OTHER STIMULANTS
• 5.4.0 SALT
• DRUGS AND ALCOHOL
• 6.2.0 TOBACCO
• 6.3.0 MARIJUANA
• 6.3.1 COCAINE
• 6.4.0 WHAT ARE THE EFFECTS OF RECREATIONAL DRUGS?
• 6.4.1 INTRAVENOUS DRUG USE PRECAUTIONS
• 6.4.2 CLEANING FITS
• 6.4.3 METHADONE AND HEPATITIS C
• HOW CAN HCV AFFECT MY EMOTIONAL LIFE?
• 7.1.1 MOOD CHANGES
• 7.1.2 DEALING WITH A CHRONIC DISEASE
• 7.1.2a ACCEPTING
• 7.1.3 DEALING WITH A LOWER LEVEL OF ENERGY
• 7.1.4 IRRITABILITY
• 7.1.5 HOW CAN HCV AFFECT MY SEX LIFE?
• 7.1.6 HELPING A FRIEND OR FAMILY MEMBER WITH HEPATITIS C
• 7.1.6a WHAT SHOULDN’T I SAY?
• 7.1.6b WHAT SHOULD I SAY?
• LIVING WITH HCV
• DEALING WITH INTERFERON THERAPY
• 9.2.0 HOW DOES INTERFERON WORK?
• 9.2.1 WHAT WILL INTERFERON ACHIEVE:
• 9.2.2 CLINICAL TRIALS:
• 9.2.3 WILL I BE ABLE TO CONTINUE WORKING WHILE I’M TAKING INTERFERON:
• 9.2.4 HOW WILL I KNOW IF THE INTERFERON IS WORKING?
• 9.3.0 SIDE EFFECTS
• 9.3.0a NAUSEA
• 9.3.0b HAIR LOSS
• 9.3.0c FATIGUE
• 9.3.0d MOUTH PROBLEMS
• 9.3.0e INFECTIONS
• 9.4.0 IMPORTANCE OF WATER
• 9.5.0 STORAGE
• 9.5.0a TRAVELING WITH INTERFERON
• 9.6.0 TIMING OF INJECTIONS
• 9.7.0 INJECTION HINTS
• 9.7.0a INJECT-EASE:
• 9.7.0b BRUISING AND DILUENT AMOUNTS
• 9.7.0c NEEDLE SIZE
• 9.8.0 HELP! I THINK I HIT A VEIN!
• 9.9.0 WHAT TO DO WHEN YOU CAN’T AFFORD THE INTERFERON
• 9.10.0 INTERFERON TREATMENT OF HCV WITH CIRRHOSIS
• WHERE DO WE GO FROM HERE?
• 10.2.0 CURRENT RESEARCH, TESTING AND CERTIFICATION OF NEW DRUGS AND TREATMENTS IN THE U.S. AND ABROAD
• EMPLOYMENT AND DISABILITY
• 11.1.1 HOW DO I HANDLE PROBLEMS ABOUT MY JOB?
• 11.1.2 WHAT PROBLEMS DO I FACE IN SEEKING DISABILITY BENEFITS?
• 11.1.3 APPLYING FOR SSI / SSDI
• 11.1.4 Winning Your Social Security Disability Claim: 15 Mistakes You Cannot Afford to Make! by Scott E. Davis, Esq. and Scott M. Harris, Esq.
• 11.1.5 Hepatitis C and Disability Benefits in British Columbia
• IMPORTANT INFORMATION
• 12.1.1 HCV INFORMATION RESOURCES AND SUPPORT GROUPS
• 12.1.1a NATIONAL (USA)
• 12.1.1b CANADA
• 12.1.1c ARGENTINA
• 12.1.1d AUSTRALIA/NEW ZEALAND
• 12.1.1e ENGLAND / SCOTLAND
• 12.1.1f GERMANY/AUSTRIA
• 12.1.1g SPAIN
• 12.1.1h URUGUAY
• 12.1.1i ISRAEL
• 12.1.2 WHAT HCV RESOURCES ARE AVAILABLE ON THE INTERNET AND USENET?
• 12.1.3 BIBLIOGRAPHY: SUGGESTED READING
• 12.1.4 WHAT NEWSLETTERS, MAGAZINES AND VIDEOS ARE AVAILABLE?
• APPENDIX A: WHERE TO GET THE CURRENT VERSION OF THIS FAQ
• APPENDIX B: COMMON ABBREVIATIONS
• APPENDIX C - SOME RECOMMENDED WEB SITES (in no particular order) ARE:
• APPENDIX D – A List of Canadian Doctors Specializing in the treatment of HCV
• APPENDIX E: History of Blood Safety, Canada’s Track Record, and Compensation Issues
• APPENDIX F: The Double Challenge of HIV/HCV Co-infection

Остановка Гепатит С - Карта сайта